open tender
watch
PT EN

Follow by RSS

Supplier totals use published shares; where unavailable, equal allocation is an estimate. Values describe contracts, not losses or verified payments. Missing values are not treated as known spending.

Exports include at most 100,000 contracts.

← Companies Company PT

LABORATORIOS VITORIA S.A.

NIF 500162220
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €1,579,854 60 contracts
At least two direct awards to the same buyer and supplier in the current and two previous calendar years, with base values reaching the configured €20,000 services/goods or €30,000 works amount.
HIGH €1,579,854 60 contracts
A2 · Late Publication €4,384,596 587 contracts
Publication is more than 10 calendar days after signing. This configured delay is not a legal deadline determination.
MEDIUM €4,384,596 587 contracts
A5 · Proximity to configured amounts €36,161 12 contracts
Base value lies within 5% below one of the configured comparison amounts. Proximity alone does not establish splitting or a legal violation.
MEDIUM €36,161 12 contracts
A6 · Low Competition €15,490 9 contracts
One bidder is recorded. Missing bidder data is not treated as one bidder; the procedure must be checked in the source.
MEDIUM €15,490 9 contracts
A9 · Price Overrun €100 1 contracts
Reported final price divided by a positive base price exceeds 1.5; high priority begins at 2.0. Only reimported records with separate contractual prices are compared.
HIGH €100 1 contracts
A9 · Abnormal Price Reduction €203,168 219 contracts
Reported final price is below half the positive base price. A reduction is descriptive and requires source review.
LOW €203,168 219 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

57
€351,242
51
€169,653
35
€151,615
18
€135,083
53
€117,977
40
€109,367
20
€105,095
21
€80,507
31
€70,237
35
€56,913
21
€49,807
11
€49,448
12
€33,163
8
€32,751
ARS Alentejo, IP
NIF 503148768
10
€31,473
8
€29,021
17
€27,803
16
€23,523
77
€23,004
14
€21,654
Page 1 of 3 · 55 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Proximity to configured amounts A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction

Page 1 of 17 · 822 contracts

Aquisição de Medicamentos ao Lab. Faes, para a ULSASI, para o ano 2026
PT · 13588344 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction
€33,600 2026-02-24
Aquisição de Medicamentos Exclusivos FAES FARMA
PT · 13364207 · Ajuste Direto Regime G...
€1,232 2026-02-12
040101142026 - MEDICAMENTO PARA A MÁQUINA DE REEMBALAGEM - PROUD - METRONIDAZOL 250 MG COMP
PT · 13433514 · Ajuste Direto Regime G...
€460 2026-02-09
261Y000026 para 2026 - CPA 2025/1303 - Medicamentos diversos
PT · 13172570 · Ao abrigo de acordo-qu...
A9 · Abnormal Price Reduction
€164,602 2026-02-05
61/640/2026 - Medicamentos Bromazepam e Norfloxacina
PT · 13511228 · Ajuste Direto Regime G...
A2 · Late Publication
€1,457 2026-01-21
Medicamentos para o sistema nervoso central
PT · 13276440 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€26,195 2026-01-21
41002526 - MEDICAMENTOS ÚNICOS FAES FARMA
PT · 13151718 · Ajuste Direto Regime G...
A2 · Late Publication
€1,116 2026-01-13
ADCM 0068/26 - MEDICAMENTOS DIVERSOS
PT · 13510079 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€1,422,566 2026-01-12
MEDICAMENTOS PARA A MÁQUINA DE REEMBALAGEM - PROUD - FAES FARMA
PT · 13151735 · Ajuste Direto Regime G...
A2 · Late Publication
€1,421 2026-01-09
Aquisição de SALIVA ARTIFICIAL BUCAL SOL PULV para a ULSASI para o ano de 2026
PT · 13641621 · Consulta Prévia
A2 · Late Publication
€2,475 2026-01-08
261G000098 - Medicamentos - SGTF
PT · 12965158 · Ajuste Direto Regime G...
A2 · Late Publication
€6,363 2026-01-08
PC 40263436 - Medicamentos do Sistema Nervoso Central para 2026
PT · 12576098 · Ao abrigo de acordo-qu...
€0 2026-01-07
ANEXO VII VARIOS
PT · 12456912 · Consulta Prévia
A9 · Abnormal Price Reduction
€1,088 2026-01-07
261Y000004/13559 - PARA 2026 - CPA 2023/0436 - Med
PT · 12425730 · Ao abrigo de acordo-qu...
A9 · Abnormal Price Reduction
€86,086 2026-01-06
Aquisição de BROMAZEPAM, ORAL, 1,5 MG, CMP, para a ULSASI, para o ano 2026
PT · 12231782 · Consulta Prévia
€160 2025-12-22
ADCM 5035/25 - MEDICAMENTOS
PT · 12537795 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€562,303 2025-12-02
4525701324 | LM 311/2025 | Aquisição de medicamentos, ao abrigo do Acordo Quadro para fornecimento de Medicamentos diversos - CP 2025/1303 - SPMS
PT · 11998714 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€2,081 2025-11-18
41/132/2026 - Medicamentos Diversos
PT · 12602737 · Ao abrigo de acordo-qu...
A2 · Late Publication
€43,635 2025-11-06
41/138/2026 - Medicamentos do Aparelho Digestivo
PT · 12603232 · Ao abrigo de acordo-qu...
A2 · Late Publication
€0 2025-11-06
61/309/2026 - Vários Medicamentos
PT · 12446872 · Ajuste Direto Regime G...
A2 · Late Publication
€2,174 2025-11-06
41/153/2026 - Medicamentos para o Sistema Nervoso Central
PT · 12648931 · Ao abrigo de acordo-qu...
A2 · Late Publication
€29,168 2025-11-06
61/5107/2025 - Medicamento Levomepromazina 25 mg/1 ml Sol inj Fr 1 ml IM
PT · 12159414 · Ajuste Direto Regime G...
A2 · Late Publication
€56 2025-10-31
Nota de encomenda 1687113232 - Aquisição de bens para os servços farmacêuticos do HP
PT · 11899111 · Ajuste Direto Regime G...
A2 · Late Publication
€1,720 2025-10-23
MEDICAMENTOS
PT · 11820489 · Ao abrigo de acordo-qu...
€250 2025-10-20
ADCM 4407/25 - MEDICAMENTOS
PT · 11872518 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€5,508 2025-10-17
Medicamentos
PT · 11954414 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€34,123 2025-10-16
Tetina anatómica em latex
PT · 11943836 · Ajuste Direto Regime G...
A2 · Late Publication
€390 2025-10-15
CIAMEMAZINA 40 MG/ML SOL ORAL FR 30 ML
PT · 11930806 · Ajuste Direto Regime G...
A2 · Late Publication
€105 2025-10-02
LM 241/2025 | Aquisição de medicamentos ao abrigo do Acordo Quadro para fornecimento Medicamentos do aparelho digestivo - CP 2025/1367 - SPMS
PT · 11817586 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€15,880 2025-10-02
ADCM 4077/25 - MEDICAMENTOS DIVERSOS
PT · 11781727 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€29,727 2025-09-25
LEVOMEPROMAZINA 25 MG/1 ML SOL INJ FR 1 ML IM
PT · 11737155 · Ajuste Direto Regime G...
€405 2025-09-22
41/4618/2025 Medicamento Gabapentina e Pregabalina
PT · 11762916 · Ao abrigo de acordo-qu...
€0 2025-09-22
ADCM 4015/25 - MEDICAMENTOS DIVERSOS
PT · 11824962 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€1,567 2025-09-16
31/4434/2025 - Medicamento "Fenitoína"
PT · 11730183 · Ao abrigo de acordo-qu...
€0 2025-09-12
ADCM 3687/25 - MEDICAMENTOS DIVERSOS
PT · 11681474 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€220,681 2025-08-22
ADCM 3681/25 - MEDICAMENTOS DIVERSOS
PT · 11668728 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€29,946 2025-08-18
Nota de encomenda 1687112347 - Aquisição de bens para os serviços farmacêuticos do HP
PT · 11908308 · Ajuste Direto Regime G...
A2 · Late Publication
€2,161 2025-08-13
PANº207/PA/HPSJD/2025 Aquisição de produtos farmacêuticos para a farmácia do HP
PT · 11735777 · Ajuste Direto Regime G...
A2 · Late Publication
€2,161 2025-08-13
MESSALAZINA 500 MG COMP GR para 2025 - Ajuste Direto N.º 92139825
PT · 11647474 · Ajuste Direto Regime G...
€248 2025-08-11
AQ URGENTE MEDICAMENTOS VÁRIOS
PT · 11944307 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€52,561 2025-08-07
040122302025-METAMIZOL MAGNESICO 575 MG CAPS
PT · 11718381 · Ajuste Direto Regime G...
A2 · Late Publication
€1,647 2025-08-04
Q1/2219/2025 - MEDICAMENTOS PARA O SISTEMA NERVOSO CENTRAL
PT · 11626335 · Ao abrigo de acordo-qu...
A9 · Abnormal Price Reduction
€603,390 2025-07-30
Diversos medicamentos bianual
PT · 11909678 · Consulta Prévia
A2 · Late Publication
€37,000 2025-07-28
Medicamentos para o Sistema Nervoso Central SPMS 2023/436
PT · 11664047 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€37,409 2025-07-22
ADCM 3133/25 - medicamentos diversos
PT · 11621644 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€11,154 2025-07-14
LEVOMEPROMAZINA 25 MG COMP
PT · 11611221 · Ajuste Direto Regime G...
A2 · Late Publication
€235 2025-07-10
Medicamentos
PT · 11666143 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€29,637 2025-07-08
levoMEPROMAZina 25 mg/1 ml Sol inj Fr 1 ml IM
PT · 11561339 · Ajuste Direto Regime G...
A2 · Late Publication
€133 2025-06-27
UI/1974/2025 - MEDICAMENTOS DIVERSOS FAES FARMA
PT · 11561343 · Ajuste Direto Regime G...
A2 · Late Publication
€933 2025-06-26
ADCM 2851/25
PT · 11558830 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€49,297 2025-06-25
Next →
Overview
Total Value Won
€31,039,388
Contracts Won
822
Score 29325 · CRITICAL RISK
NIF
500162220
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned